Skip to main content

Want a detailed portfolio tracker?

iBio (IBIO) P/E (2011 - 2026)

iBio (IBIO) P/E from Jun 30, 2011 to Jul 21, 2026. The TTM iBio (IBIO) P/E is -1.09. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of iBio (IBIO)

YearP/EChange
2026-1.09-12.66%
2025-1.25+13.15%
2024-1.11+293.81%
2023-0.28-90.38%
2022-2.93-97.22%
2021-105.12+1.04%
2020-104.04+2979.33%
2019-3.38-50.92%
2018-6.88-35.00%
2017-10.59-65.06%
2016-30.31-46.19%
2015-56.33-33.64%
2014-84.89+99.09%
2013-42.64+9.13%
2012-39.07-82.56%
2011-223.98N/A

Comparison iBio (IBIO) P/E with competitors

iBio (IBIO) P/E is -1.09.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.16%
NBYStablecoin Development Corp0.00-100.39%
ENLVEnlivex Ltd0.07-106.83%
FGENFibroGen Inc0.24-121.93%
CHRSCoherus Biosciences Inc0.85-177.52%
FBIOFortress Biotech Inc0.95-186.70%
ORMPOramed Pharmaceuticals Inc1.50-237.31%
AGENAgenus Inc3.01-374.94%
INVAInnoviva Inc3.15-388.13%
VXRTVaxart Inc3.55-424.28%
CRMDCorMedix Inc3.63-431.47%
CVACCureVac N.V.4.45-506.12%
GLPGGalapagos NV4.86-543.87%
SRPTSarepta Therapeutics Inc4.88-545.99%
ABEOAbeona Therapeutics Inc5.39-592.16%
ABUSArbutus Biopharma Corp5.60-611.17%
ZVRAZevra Therapeutics Inc5.89-637.81%
SPROSpero Therapeutics Inc6.23-668.98%
CGENCompugen Ltd6.31-676.79%
RIGLRigel Pharmaceuticals6.87-727.78%
SLXNSilexion Therapeutics Corp7.30-766.51%
OMEROmeros Corporation9.26-945.81%
AUPHAurinia Pharmaceuticals Inc9.58-975.61%
PLXProtalix BioTherapeutics Inc10.89-1094.92%
ACADAcadia Pharmaceuticals Inc11.73-1171.43%
TBPHTheravance Biopharma Inc12.26-1220.18%
ADMAAdma Biologics Inc12.42-1234.43%
HRMYHarmony Biosciences Holdings Inc13.82-1362.51%
SABSSAB Biotherapeutics Inc14.14-1391.38%
NAGENiagen Bioscience Inc14.82-1453.68%
INCYIncyte Corp15.82-1545.43%
REGNRegeneron Pharmaceuticals Inc15.86-1548.55%
PBYIPuma Biotechnology Inc17.32-1681.84%
CPRXCatalyst Pharmaceuticals Inc17.44-1693.13%
EXELExelixis Inc17.54-1702.14%
TGTXTG Therapeutics Inc18.97-1832.60%
MDXGMimedx Group Inc20.55-1977.53%
XOMAXOMA Royalty Corp22.87-2189.72%
ARGXArgen X SE24.30-2319.75%
CTMXCytomX Therapeutics Inc24.82-2367.54%
XOMAOXOMA Royalty Corp25.34-2415.38%
HALOHalozyme Therapeutics Inc25.62-2440.86%
XOMAPXOMA Royalty Corp25.67-2445.10%
VRTXVertex Pharmaceuticals Inc27.99-2657.46%
RPRXRoyalty Pharma plc - Class A28.69-2720.75%
SLNOSoleno Therapeutics Inc29.02-2750.70%
ASNDAscendis Pharma A/S30.09-2848.47%
LGNDLigand Pharmaceuticals Inc - Class B37.91-3563.46%
APLSApellis Pharmaceuticals Inc39.02-3664.79%
BMRNBiomarin Pharmaceutical Inc42.21-3956.27%
KRYSKrystal Biotech Inc45.34-4242.36%
ONCBeiGene Ltd69.54-6452.88%
PHARPharming Group N.V.75.03-6953.98%
TECHBio-Techne Corp101.96-9414.43%
VCELVericel Corp109.92-10141.89%
ALNYAlnylam Pharmaceuticals Inc117.96-10876.72%
GMABGenmab140.29-12916.29%
TLXTelix Pharmaceuticals Ltd162.15-14913.50%
CORTCorcept Therapeutics Inc212.86-19545.64%